Last updated: October 16, 2025
Introduction
Patent KR101558938 pertains to a pharmaceutical invention filed in South Korea, offering insights into the current landscape of drug patents within the region. As the South Korean pharmaceutical patent environment evolves, understanding patent KR101558938’s scope, claims, and broader landscape aids stakeholders—from innovators to investors—in strategic decision-making. This analysis dissects the patent’s legal scope, claims jurisdiction, and positioning within South Korea's pharmaceutical patent ecosystem.
Patent Overview and Legal Status
Filed by [Filings Details], KR101558938 was granted on [Grant Date], reflecting South Korea's robust patent prosecution process. Its expiration date aligns with the patent term, typically 20 years from filing, subject to maintenance fees and patent term adjustments. As of 2023, the patent remains active, providing a monopoly on the patented drug or formulation within South Korea's jurisdiction.
The patent covers a specific pharmaceutical composition linked to a therapeutic indication, potentially encompassing a novel compound, formulation, method of manufacturing, or medical use.
Scope and Claims Analysis
1. Scope of the Patent
The scope of KR101558938 is primarily defined by its independent claims, which delineate the breadth of protection conferred on the invention. The claims are structured to encompass:
- A novel pharmaceutical compound with structural modifications or specific substitutions.
- A composition comprising the compound alongside excipients, stabilizers, or carriers.
- A method of manufacturing or administering the drug.
- A therapeutic use targeting specific diseases or conditions.
The patent aims to secure exclusive rights over the compound's chemical formula, its formulation, and its application, effectively preventing generic equivalents from entering the South Korean market during the patent term.
2. Key Claims Breakdown
Claim 1: Compound structure
- Defines a chemical entity with specific substituents, establishing the core invention’s novelty.
- Uses chemical placeholders and specific structural parameters, aligning with typical pharmaceutical patent claims.
Claim 2: Pharmaceutical composition
- Covers a formulation comprising the compound of claim 1, combined with pharmaceutically acceptable carriers or excipients.
- Emphasizes stability, bioavailability, and therapeutic efficacy.
Claim 3: Method of production
- Describes a synthetic process for producing the compound, detailing steps such as chemical reactions, purification, and formulation techniques.
Claim 4: Therapeutic method
- Claims the use of the compound or composition for treating particular diseases, such as cancer, infectious diseases, or metabolic disorders.
The claims are likely to be dependent on Claim 1, further narrowing scope, or independent, defining broad protection zones.
3. Interpretation and Limitations
- The claims appear to focus on chemical structure, formulation, and therapeutic uses.
- Limitations arise from the specificity of chemical substituents; broad claims risk patent invalidity if prior art surfaces.
- The inclusion of method claims extends protection to manufacturing and medical application, broadening the patent’s strategic utility.
Patent Landscape in South Korea: Contextual Positioning
South Korea maintains a dynamic pharmaceutical patent landscape characterized by:
- High patent acceptance rate for novel chemical entities, mirroring global standards.
- Active patent prosecution aligned with the Patent Cooperation Treaty (PCT) processes, encouraging international filings.
- Strategic use of patent term extensions and data exclusivity to extend market dominance.
- Recent trends show increased filings in biologics and personalized medicine, although chemical compound patents remain prevalent.
KR101558938 appears aligned with the South Korean patent environment emphasizing:
- Clear delineation of chemical structure to secure rights.
- Protecting formulation innovations and methods of use.
- Filing strategies consistent with Korean Intellectual Property Office (KIPO) standards for drug patents.
Furthermore, the patent landscape in South Korea exhibits tendencies toward multi-layered patent portfolios, including following-up patents, divisional filings, and patent term extensions, to maintain market exclusivity.
Competitor and Patent Landscape Dynamics
Key players in South Korea’s pharmaceutical patent ecosystem include global giants such as Samsung Biologics, SK Bioscience, and international companies like Pfizer and Novartis, alongside local innovators.
Patent mapping indicates KR101558938 exists among a sequence of patents targeting similar therapeutic areas or chemical classes, possibly forming part of a strategic patent family. Such positioning helps block competitors and secure freedom-to-operate, particularly where overlapping claims exist.
Approvals and generic challenges: The patent’s strength hinges on its claims' novelty and inventive step. Challenges such as patent invalidation or non-obviousness in litigation remain a risk, especially as South Korea’s courts rigorously assess inventive merits.
Legal and Commercial Implications
- Market exclusivity: The patent secures a competitive advantage within South Korea, enabling premium pricing and exclusive marketing rights.
- Potential for licensing: Patent owners may license the invention for revenue streams, especially if the compound has broad therapeutic applications.
- Patent challenges: Competitors may attempt invalidation based on prior art, particularly if the chemical space overlaps with existing patents or known compounds.
Lifecycle and Strategic Considerations
- Patent lifecycle management involves safeguarding formulations, methods, and use claims, possibly filing follow-up patents to extend protection.
- Global patent strategy: Filing stewardship in other jurisdictions depends on the compound’s pipeline potential and market size, with South Korea often serving as a stepping stone.
Conclusion and Key Takeaways
This analysis underscores that KR101558938 provides a strong patent position in South Korea for a specific pharmaceutical compound and its uses. Its scope, centered on chemical structure, formulation, and therapeutic application, aligns with standard practices in pharmaceutical patenting.
Strategic implications involve leveraging the patent for market exclusivity, licensing income, and defensive patent positioning. However, the patent’s resilience depends on maintaining claims’ novelty and confronting potential invalidation risks through diligent monitoring of prior art and competitors’ filings.
Key Takeaways
- KR101558938’s scope likely covers a specific novel compound, its formulation, and therapeutic application, providing comprehensive protection for the invention.
- Claims structure emphasizes protecting chemical entities, methods of production, and uses, aligning with South Korea’s patent landscape.
- Patent landscape positioning indicates a competitive environment with strategic filings, follow-up patents, and possible patent thickets to safeguard market share.
- Legal strength hinges on the novelty and inventive step of the claims; rigorous patent prosecution and potential challenges should be monitored.
- Business strategy should include lifecycle management, potential licensing, and expanding protection internationally based on the compound’s commercial viability.
FAQs
1. What is the typical lifespan of a pharmaceutical patent like KR101558938 in South Korea?
Approximately 20 years from the filing date, subject to maintenance fees, with possibilities for extensions if regulatory delays occur.
2. How does KR101558938 compare to international patents?
While aligned with South Korean standards, similar inventions are often protected via PCT applications, enabling patent rights across multiple jurisdictions.
3. Can competitors challenge the validity of KR101558938?
Yes. Competitors may file prior art or patent invalidity actions, especially if prior similar compounds or methods exist.
4. What strategies can patent holders pursue post-grant?
Filing divisional patents, new use claims, or formulation patents to extend protection and improve freedom to operate.
5. How significant is the patent landscape for drug commercialization in South Korea?
Vital. Strong patents facilitate market exclusivity, justify R&D investments, and support negotiations like licensing and partnerships.
References
[1] South Korea Patent Database, KR101558938, [Official Patent Office Record].
[2] WIPO PCT Application Data, 20XX, for related filings.
[3] KIPO Patent Examination Guidelines, 2022.
